369 related articles for article (PubMed ID: 33536109)
1. Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review.
Lees R; Hines LA; D'Souza DC; Stothart G; Di Forti M; Hoch E; Freeman TP
Psychol Med; 2021 Feb; 51(3):353-364. PubMed ID: 33536109
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.
Baker AL; Hides L; Lubman DI
J Clin Psychiatry; 2010 Mar; 71(3):247-54. PubMed ID: 20331929
[TBL] [Abstract][Full Text] [Related]
3. Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.
Reeves LE; Gaudiano BA; Metrik J; Guzman Holst C; Morena A; Sydnor VJ; Weinstock LM; Epstein-Lubow G
J Dual Diagn; 2018; 14(3):171-180. PubMed ID: 30265850
[TBL] [Abstract][Full Text] [Related]
4. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults.
Leadbeater BJ; Ames ME; Linden-Carmichael AN
Addiction; 2019 Feb; 114(2):278-293. PubMed ID: 30276906
[TBL] [Abstract][Full Text] [Related]
5. Integrated cognitive-behavioral therapy for comorbid cannabis use and anxiety disorders: The impact of severity of cannabis use.
Buckner JD; Morris PE; Zvolensky MJ
Exp Clin Psychopharmacol; 2021 Jun; 29(3):272-278. PubMed ID: 34264732
[TBL] [Abstract][Full Text] [Related]
6. Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys.
Onaemo VN; Fawehinmi TO; D'Arcy C
J Affect Disord; 2021 Feb; 281():467-475. PubMed ID: 33360749
[TBL] [Abstract][Full Text] [Related]
7. Cannabis use and cannabis use disorder.
Connor JP; Stjepanović D; Le Foll B; Hoch E; Budney AJ; Hall WD
Nat Rev Dis Primers; 2021 Feb; 7(1):16. PubMed ID: 33627670
[TBL] [Abstract][Full Text] [Related]
8. Cannabis Use and its Association with Psychological Disorders.
Urits I; Gress K; Charipova K; Li N; Berger AA; Cornett EM; Hasoon J; Kassem H; Kaye AD; Viswanath O
Psychopharmacol Bull; 2020 May; 50(2):56-67. PubMed ID: 32508368
[TBL] [Abstract][Full Text] [Related]
9. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.
Bhardwaj AK; Mills L; Doyle M; Sahid A; Montebello M; Monds L; Arunogiri S; Haber P; Lorenzetti V; Lubman DI; Malouf P; Harrod ME; Dunlop A; Freeman T; Lintzeris N
BMC Psychiatry; 2024 Mar; 24(1):175. PubMed ID: 38433233
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cannabis use disorders in people with schizophrenia spectrum disorders - a systematic review.
Hjorthøj C; Fohlmann A; Nordentoft M
Addict Behav; 2009; 34(6-7):520-5. PubMed ID: 19268481
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of technology-based psychotherapeutic interventions for decreasing cannabis use in patients with psychosis.
Tatar O; Bastien G; Abdel-Baki A; Huỳnh C; Jutras-Aswad D
Psychiatry Res; 2020 Jun; 288():112940. PubMed ID: 32344316
[TBL] [Abstract][Full Text] [Related]
12. Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders: A pilot randomized controlled trial.
Buckner JD; Zvolensky MJ; Ecker AH; Schmidt NB; Lewis EM; Paulus DJ; Lopez-Gamundi P; Crapanzano KA; Bakhshaie J
Behav Res Ther; 2019 Apr; 115():38-45. PubMed ID: 30442329
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Treatment of Cannabis-Related Disorders: A Narrative Review.
Gorelick DA
Curr Pharm Des; 2016; 22(42):6409-6419. PubMed ID: 27549375
[TBL] [Abstract][Full Text] [Related]
14. Relationship of Cannabis Use Disorder and Irritable Bowel Syndrome (IBS): An Analysis of 6.8 Million Hospitalizations in the United States.
Patel RS; Goyal H; Satodiya R; Tankersley WE
Subst Use Misuse; 2020; 55(2):281-290. PubMed ID: 31573379
[No Abstract] [Full Text] [Related]
15. [Related, induced and associated psychiatric disorders to cannabis].
Laqueille X
Rev Prat; 2005 Jan; 55(1):30-4. PubMed ID: 15801394
[TBL] [Abstract][Full Text] [Related]
16. [Motivational interviewing for cannabis users with psychotic disorders].
Bonsack C; Montagrin Y; Favrod J; Gibellini S; Conus P
Encephale; 2007 Oct; 33(5):819-26. PubMed ID: 18357854
[TBL] [Abstract][Full Text] [Related]
17. The impact of cannabis use on clinical outcomes in recent onset psychosis.
Barrowclough C; Gregg L; Lobban F; Bucci S; Emsley R
Schizophr Bull; 2015 Mar; 41(2):382-90. PubMed ID: 25011381
[TBL] [Abstract][Full Text] [Related]
18. Reasons for cannabis use in psychosis.
Schofield D; Tennant C; Nash L; Degenhardt L; Cornish A; Hobbs C; Brennan G
Aust N Z J Psychiatry; 2006; 40(6-7):570-4. PubMed ID: 16756582
[TBL] [Abstract][Full Text] [Related]
19. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
Tomko RL; Baker NL; Hood CO; Gilmore AK; McClure EA; Squeglia LM; McRae-Clark AL; Sonne SC; Gray KM
Psychopharmacology (Berl); 2020 Feb; 237(2):479-490. PubMed ID: 31712969
[TBL] [Abstract][Full Text] [Related]
20. A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness.
Kozak K; H Smith P; Lowe DJE; Weinberger AH; Cooper ZD; Rabin RA; George TP
Am J Drug Alcohol Abuse; 2021 Sep; 47(5):535-547. PubMed ID: 34280058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
